Medicare Prescription Drug, Improvement, and Modernization Act of 2003 PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Medicare Prescription Drug, Improvement, and Modernization Act of 2003 PDF full book. Access full book title Medicare Prescription Drug, Improvement, and Modernization Act of 2003 by United States. Congress. Download full books in PDF and EPUB format.
Author: United States. Congress
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Get Book Here
Book Description
Author: United States. Congress
Publisher:
ISBN:
Category : Electronic government information
Languages : en
Pages : 850
Get Book Here
Book Description
Author: CCH Incorporated
Publisher:
ISBN:
Category : Medicare
Languages : en
Pages : 681
Get Book Here
Book Description
Author: Jordan R Covvey
Publisher:
ISBN: 9781641760799
Category : Medicine
Languages : en
Pages : 0
Get Book Here
Book Description
"Public Health in Pharmacy Practice: A Casebook is a collaboration of over thirty-five experts in public health pharmacy. The twenty-one chapters cover a broad array of topics relevant to pharmacy applications of public health: cross-cultural care, health literacy and disparities, infectious disease, health promotion and disease prevention, medication safety, women's and rural health and more. Each chapter contains learning objectives and an introduction to the topic, followed by a case and questions. The chapter closes with commentary from the authors and patient-oriented considerations for the topic at hand"--Publisher's description
Author: Anna Cook
Publisher:
ISBN: 9781457856631
Category :
Languages : en
Pages : 48
Get Book Here
Book Description
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the Medicare Modernization Act, or MMA) substantially expanded the federal Medicare program by creating the prescription drug benefit known as Part D. In FY 2013, Medicare Part D covered 39 million people. The federal government spent $59 billion net of premiums on Part D in that year; after accounting for certain payments from states under the program, the net federal cost was $50 billion, which represented 10% of net federal spending for Medicare. A combination of broader trends in the prescription drug market and lower-than-expected enrollment in Part D has contributed to much lower spending for the program than projected when the MMA became law in 2003. This report examines the federal budgetary cost and competitive design of Medicare Part D and compares Medicare Part D and Medicaid Fee for Service. Figures and tables. This is a print on demand report.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Navarro
Publisher: Jones & Bartlett Publishers
ISBN: 076378883X
Category : Medical
Languages : en
Pages : 659
Get Book Here
Book Description
Managed Care Pharmacy Practice, Second Edition offers information critical to the development and operation of a managed care pharmacy program. The text also covers the changes that have taken place within the delivery of pharmacy services, as well as the evolving role of pharmacists.
Author: United States. Congress. House. Committee on Ways and Means
Publisher:
ISBN:
Category :
Languages : en
Pages : 176
Get Book Here
Book Description
Author: United States. Congress. House. Committee on Rules
Publisher:
ISBN:
Category : Bills, Legislative
Languages : en
Pages : 136
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Government publications
Languages : en
Pages : 664
Get Book Here
Book Description
Author: United States. Congress
Publisher:
ISBN: 9780160679766
Category : Medical care, Cost of
Languages : en
Pages : 850
Get Book Here
Book Description
